corporal, you limit it to two options.
In my book failure or success is decided at the END not while the process is ongoing. The Sunrise trial came to an end, the Bavi Study far from (prove see upcoming Bavi related events and presentations by the US if not the world most reputed scientist and organisation in Oncology)).
Birge, Wolchok, Brekken, Antonia, Gabrilovich, NCCN, Memorial Sloan Klettering, AstraZeneca, etc...
Amazin that thye would NOW that, according you, Bavi failed get even more invested then before and are publicly going to talk about Bavituximab.
So maybe BINARY logic doesn't apply well in this case.